热门资讯> 正文

Kura Oncology在大量首席执行官股票购买数小时后上涨

2026-08-18 05:31

Kura Oncology(KURA) 0
XMax Inc(XMAX) 0

Kura Oncology (KURA) is up ~5% in after-hours trading Monday following the disclosure CEO Troy Wilson bought 100,000 shares through a trust.
One Fish Two Fish Revocable Trust acquired the shares on Monday at an average price of $11.12, giving the purchase a value of ~$1.1M.

More on Kura Oncology

Kura Oncology, Inc. (KURA) Q2 2026 Earnings Call Transcript
Kura Oncology, Inc. (KURA) Discusses Updated FIT 001 Trial Results for Darlifarnib and Cabozantinib in Renal Cell Carcinoma - Slideshow
Kura Oncology, Inc. (KURA) Discusses Updated FIT 001 Trial Results for Darlifarnib and Cabozantinib in Renal Cell Carcinoma Transcript
Kura outlines $90M-$110M 2027 collaboration revenue while targeting 2028 KOMET-017 topline results
Kura Oncology GAAP EPS of -$0.77 beats by $0.12, revenue of $11.8M misses by $8.38M

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。